KYNTRA BIO, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
KYNTRA BIO, INC. (KYNB) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $15.30 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-09
- KYNTRA BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was $15.30M, a 34.64% decline year-over-year.
- KYNTRA BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $20.00M.
- KYNTRA BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $9.54M, a 11.14% increase year-over-year.
- KYNTRA BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $16.92M, a 708.41% increase year-over-year.
- KYNTRA BIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $69.87M, a 955.06% increase from fiscal 2016.
- KYNTRA BIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $6.62M.
- KYNTRA BIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$5.87M.
- KYNTRA BIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$107.29M, a 1095.44% decline from fiscal 2013.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | $15.30M 10-Q · filed 2018-05-09 | $35.30M derived: sum of 2 quarters · filed 2018-05-09 | $44.84M derived: sum of 3 quarters · filed 2018-05-09 | $61.76M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $29.54M derived: sum of 2 quarters · filed 2018-02-27 | $46.46M derived: sum of 3 quarters · filed 2018-02-27 | $69.87M 10-K · filed 2018-02-27 | |
| 2017-09-30 | $9.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $26.46M derived: sum of 2 quarters · filed 2017-11-08 | $49.87M 10-Q · filed 2017-11-08 | $40.75M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-06-30 | $16.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $40.33M 10-Q · filed 2017-08-07 | $31.21M derived: sum of 3 quarters · filed 2018-05-09 | $39.80M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-03-31 | $23.41M 10-Q · filed 2018-05-09 | $14.29M derived: sum of 2 quarters · filed 2018-05-09 | $22.88M derived: sum of 3 quarters · filed 2018-05-09 | $24.97M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | -$9.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$530.00K derived: sum of 2 quarters · filed 2018-02-27 | $1.56M derived: sum of 3 quarters · filed 2018-02-27 | $6.62M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $8.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $10.68M derived: sum of 2 quarters · filed 2017-11-08 | $15.74M 10-Q · filed 2017-11-08 | $4.03M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $7.15M 10-Q · filed 2017-08-07 | -$4.55M derived: sum of 3 quarters · filed 2018-02-27 | -$4.76M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | $5.06M 10-Q · filed 2017-05-09 | -$6.65M derived: sum of 2 quarters · filed 2018-02-27 | -$6.86M derived: sum of 3 quarters · filed 2018-02-27 | -$5.36M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | -$11.71M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$11.91M derived: sum of 2 quarters · filed 2018-02-27 | -$10.42M derived: sum of 3 quarters · filed 2018-02-27 | -$5.87M 10-K · filed 2018-02-27 | |
| 2015-09-30 | -$208.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $1.29M derived: sum of 2 quarters · filed 2016-11-08 | $5.84M 10-Q · filed 2016-11-08 | $14.30M 10-Q · filed 2015-11-12 | -$134.46M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $6.05M 10-Q · filed 2016-08-08 | -$134.25M derived: sum of 3 quarters · filed 2017-03-01 | -$130.84M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $4.55M 10-Q · filed 2016-05-09 | -$135.74M derived: sum of 2 quarters · filed 2017-03-01 | -$132.33M derived: sum of 3 quarters · filed 2017-03-01 | -$114.95M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | -$140.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$136.88M derived: sum of 2 quarters · filed 2017-03-01 | -$119.50M derived: sum of 3 quarters · filed 2017-03-01 | -$107.29M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $3.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $20.79M derived: sum of 2 quarters · filed 2015-11-12 | $33.00M 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $17.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $29.59M 10-Q · filed 2015-08-13 | |||
| 2014-03-31 | $12.21M 10-Q · filed 2015-05-12 | ||||
| 2013-12-31 | $10.78M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |